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    Abstract 
Activation-induced cytidine deaminase (AID) is an enzyme that initiates the 
secondary antibody diversification events of somatic hypermutation (SHM) and class 
switch recombination (CSR). AID is expressed in activated B lymphocytes and 
deaminates cytidines to uridines, thus introducing mutations and/or double-strand breaks 
throughout the immunoglobulin (Ig) locus. Although AID activity is mostly targeted to 
the Ig locus, it mutates many other genes at lower rates and this off-target activity induces 
genomic lesions leading to transformation of B cells. The structure of AID has not been 
solved, which is partially the reason that several important questions remain unanswered 
about its mechanism of action. Our lab has recently shown that AID from different 
species has disparate rates of deamination, and that the deamination rate of AID from 
each species is thermosensitive, such that fish AID are cold-adapted relative to human 
AID. Here, we have measured the activity of purified AID from human, zebrafish, 
channel catfish, pufferfish (takifugu), and hybrid AID containing various parts of the 
aforementioned, over a wide range and fine increments of temperatures. Our aim was to 
elucidate the relationship between thermosensitivity of AID and its primary structure, by 
identifying region(s) and/or residue(s) within the enzyme that affect thermosensitivity. 
We found that this characteristic is mostly determined by the C-terminus in the sense that 
swapping this region resulted in transferring thermosensitivity patterns from the donor 
enzyme. We also found that AID activity is not always optimal at native physiological 
temperature, such that human AID is optimal at 32°C instead of 37°C. Based on our data, 
we postulated that this finding may have implications for evolution of AID. Overall, our 
work has shed light on mechanistic features of AID as well as aspects on its evolution. 
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1. Introduction 
1.1 The immune system: innate and adaptive immunity 
The immune system is comprised of a collection of biological structures 
and processes that function together to provide protection against a wide variety of 
insults; such as viruses, bacteria, tumour cells, and parasites (Warrington et al., 2011; 
Lanasa & Weinberg, 2011). There are two arms: The innate immune system and the 
adaptive immune system. The innate immune system is the first line of defense against 
foreign pathogens. This system is comprised of antigen-independent defense mechanisms 
such as chemical and physical barriers (e.g. lysozymes and mucous membranes), plasma 
proteins (complement), and cells (e.g. natural killer cells, macrophages, and dendritic 
cells). These mechanisms respond immediately or within a short time to the invading 
pathogens in a non-specific way, but do not last long and have no immunologic memory. 
In contrast, adaptive immune responses are the second line of defense and take days or 
weeks to develop, but last long and have memory to recognize subsequent encounters 
with the same antigen and respond in a stronger and faster manner. There are two types of 
adaptive immunity characterized as antigen-specific responses: First, humoral immune 
responses, mediated by B lymphocytes, second, cell-mediated immune responses, 
mediated by T lymphocytes (Warrington et al., 2011; Litman et al., 2005; Fleisher & 
Tomar, 1997). 
 B and T lymphocytes are the main cellular components of the adaptive immune 
system. T lymphocytes mature in the thymus and have several subsets: T helper cells 
(Th cells) and cytotoxic T cells (also known as TC or Cytotoxic T Lymphocytes, CTLs) 
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are the major subtypes of T lymphocytes. In response to antigens T helper cells produce a 
wide range of cytokines that induce, promote and direct immune responses, whereas 
cytotoxic T cells produce effective and potent cytotoxins that target and kill infected cells. 
On the other hand, B lymphocytes mature in the bone marrow, and leave it after 
maturation. Naive B cells, which have never been exposed to an antigen, express unique 
membrane-bound antibodies (antigen binding receptors) on their surfaces. These primary 
antigen binding receptors have low binding affinity to specific foreign pathogens. Once 
these cells are activated by a specific antigen, they migrate to germinal center structures 
in lymph nodes. There, they proliferate and differentiate into antibody-producing B cells 
(plasma cells) that produce large amounts of antibodies, which function to neutralize the 
activating antigen(s). However, some of the B cells do not differentiate into antibody-
producing plasma cells; instead they differentiate into long-lived memory cells, which 
become the effector cells of subsequent immunological memory. Besides producing 
antibodies, B cells also produce and release cytokines and function as antigen presenting 
cells (Warrington et al., 2011; Litman et al., 2005; Fleisher & Tomar, 1997; Gellert, 
2002). 
There are five subclasses of antibodies (Immunoglobulins) known as IgM, IgA, 
IgG, IgD, and IgE. Immunoglobulins are glycoprotein molecules each monomer of which 
is comprised of four polypeptide chains: Two identical heavy chains and two identical 
light chains linked together by disulphide bonds to form a “Y” shaped protein (figure 1). 
The amino acid sequences at the end of the heavy and light chains vary extensively 
among immunoglobulins to form a antigen-binding site that confers to the antibody its 
unique antigen binding properties. The bottom of the “Y” shaped molecule, known as Fc 
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region (constant region) determines the effector function of the immunoglobulin by 
interacting with different cell surface receptors.  The Fc portion is identical within 
antibodies of the same isotype and varies only from one isotype to another (Woof & 
Burton, 2004; Fleisher & Tomar, 1997).  
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Figure 1: Schematic diagram of IgG. 
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Figure 1: Schematic diagram of IgG. 
Each immunoglobulin (Ig) monomer consists of four polypeptides: two identical heavy 
chains and two identical light chains joined to form a "Y" shaped molecule. The variable 
regions of light and heavy chains form the antigen-binding sites of the Ig molecules. Each 
Ig contains two antigen-binding sites. The Fc region plays a significant role in 
determining the effector functions of immunoglobulin. 
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1.2 V(D)J recombination: primary antibody diversification                                                                                             
The vertebrate immune system generates great diversity in its pre-immune antigen 
receptors even before encountering antigens. This massive repertoire of antigen-binding 
receptors is achieved through a process known as V(D)J recombination (V=variable, 
D=diversity, and J= joining  gene segments). V(D)J rearrangement is a highly specialized 
and site-specific DNA recombination process that occurs during early B and T 
lymphocyte development to create functional immunoglobulins (Igs) and T cell receptors 
(TCRs). This genetic rearrangement is mediated by two lymphoid-specific recombination 
activating gene products known as RAG-1 and RAG-2. This sophisticated mechanism is 
the only recognized site-specific rearrangement process in higher eukaryotes. In 
mammals, there are seven well-identified antigen receptors loci: T cell receptor α, β, γ, 
and δ loci, as well as κ, λ, and IgH loci. During B and T lymphocyte development, 
random recombination of V, D and J gene segments joins them together at the DNA level 
to be transcribed and then translated to form the variable and the constant regions of the B 
and T cell receptors (figure 2). In addition to this combinatorial diversification 
mechanism, there is considerable imprecision in the joining of V, D and J segments that 
further adds diversity to regions of the gene that encode antigen binding sites of B and T 
cell receptors (Gellert, 2002; Matsuda et al., 1998).  
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(Modified from Janway 2001) 
Figure 2: V(D)J recombination. 
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Figure 2: V(D)J recombination. 
V(D)J recombination is a type of site-specific DNA rearrangement that takes place in 
primary lymphoid organs (bone marrow and thymus) early during B and T cell 
development. V(D)J recombination brings together gene segments to encode functional  
immunoglobulins (Igs) and T cell receptors (TCRs) in B and T cells, respectively. During 
B cell maturation, gene segments for both heavy (VDJ) and light (VJ) chains are 
randomly assembled. Each B cell ends up with functional genes that code for light and 
heavy chains. Heavy and light chains associate to form an antibody as a membrane bound 
receptor. The cleavage phase of V(D)J recombination is mediated by two recombination 
activating gene products known as RAG-1 and RAG-2. The joining phase is mediated by 
non homologous end joining (NHEJ)-type DNA repair processes that are not cell type-
specific. 
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1.3 Secondary diversification of the antibody repertoire 
V(D)J recombination generates diversity in the primary antibody repertoire of 
developing B lymphocytes in the bone marrow. These pre-immune B cell receptors on the 
surface of the naive B cells are produced without previous encounter with any antigens. 
Despite the fact that the antigen binding sites of these initial receptors cover a wide 
spectrum of specificities, they have low affinities for any specific antigen. However, 
following exposure to an immunogen, B cells get activated, and secondary antibody 
diversifications take place to generate antibodies with switched isotype and increased 
binding affinity for specific antigenic determinants. This further diversification occurs 
when activated B cells migrate to the germinal centers of the lymph nodes, and the 
antibody genes are further mutated and/or recombined through processes known as 
somatic hypermutation (SHM) and class switch recombination (CSR) (figure 3) 
(Muramatsu et al., 2000; Okazaki et al., 2002; Revy et al., 2000). 
SHM is the mechanism by which point mutations are introduced in the rearranged 
variable V(D)J exon of immunoglobulin genes. The rate of these random mutations in 
activated B cells is approximately one million times higher than the rate of spontaneous 
mutations in somatic cells (Odegard & DG, 2006; Rajewsky, 1996). These point 
mutations will result in some B cell receptors with improved affinity and others with 
reduced affinity for a specific antigen. Due to enhanced binding to a limited pool of 
antigen, B cells that express antigen receptors on their membrane with high affinity will 
be positively selected while other B cells expressing receptors with lower affinity to 
antigens will be eliminated by apoptosis. The processes of secondary antibody 
diversification, followed by cellular selection for B cells that express antibodies with 
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enhanced affinity for antigens, are collectively known as affinity maturation (Or-Guil et 
al., 2007; Rajewsky, 1996; Neuberger et al., 2000; Ziqiang et al., 2004). Besides affinity 
maturation, activated B cells will also undergo CSR. This mechanism involves 
recombination of the constant (C) region of the antibody genes with downstream C 
regions, thus replacing the primary C region (Cμ heavy-chain). This results in a switch 
from the initial IgM isotype to IgA, IgE, or IgG. Since the antigen binding site does not 
change during CSR, the antigen specificity of the antibody will not be altered. Instead, the 
antibody will be able to interact with various effector molecules to carry out different 
effector functions (Stavenzer et al., 2008; de Yebenes & Ramiro, 2006).   
The secondary antibody diversification events of SHM and CSR are initiated by 
an enzyme called activation-induced cytidine deaminase (AID) (Muramatsu et al., 1999; 
Muramatsu et al., 2000; Revy et al., 2000; Martin et al., 2002; Okazaki et al., 2002; 
Barreto et al., 2005; Neuberger et al., 2005). AID is expressed specifically in activated B 
lymphocytes; the processes of SHM and CSR takes place only in these cells. The 
significance of AID in triggering the secondary antibody diversification was revealed by 
interrupting the expression of AID in mice, which resulted in lack of class switch 
recombination and somatic hypermutation. In addition, individuals with inherited defects 
in the AID gene also lack CSR and SHM, which results in an accumulation of IgM and 
absence of affinity maturation. Individuals with such a disorder suffer from a syndrome 
known as hyper IgM type2 immunodeficiency. Generally, in hyper IgM syndrome, B 
lymphocytes continue producing IgM antibodies, leading to high levels of IgM, and a 
lack of all other antibody isotypes (IgA, IgG, and IgE). This results in recurrent bacterial 
infections, and other diseases as well as lymph node hyperplasia caused by giant germinal 
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centers, presumably because B cells do not undergo proper affinity maturation, or because 
AID activity can also result in B cell death, either through mutating its antibody so that it 
no longer recognizes antigen, or through its off-target mutating genotoxic effects in B 
cells (Durandy et al., 2006; Dooley et al., 2006; Revy et al., 2000). 
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(Modified from Kinoshita & Honjo, 2001) 
Figure 3:  Somatic hypermutation (SHM) and class switch recombination (CSR). 
 
 
 
 
 
 
 
13 
 
Figure 3:  Somatic hypermutation (SHM) and class switch recombination (CSR). 
          The Secondary antibody diversification events of somatic hypermutation (SHM) and 
class switch recombination (CSR) are initiated by an enzyme called activation-induced 
cytidine deaminase (AID). These processes occur in the peripheral lymphoid tissues 
(germinal centers), whereas V(D)J recombination occurs in the bone marrow. SHM 
introduces point mutations in the rearranged variable V(D)J exon of immunoglobulin 
genes, leading to a tremendous number of variants of the recombined antibodies some of 
which change the initially weak and/or broadly binding antibodies into stronger and more 
specifically-binding variants. CSR involves double strand breaks (DSB) in switch (S) 
sequences upstream of constant (C) exons, followed by recombination. CSR brings the 
downstream constant (C) region in the proximity of the V region by mediating 
recombination between Sμ and another downstream S region. Deleted DNA is looped out 
as circular DNA. This process results in the antibody isotype being changed from IgM to 
IgA, IgE, or IgG. 
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1.4 The mechanisms of the mutagenic activity of AID in initiating secondary     
antibody diversification and oncogenesis 
  Ig genes are the main targets of AID. It plays a vital role in achieving antibody 
diversity by initiating the DNA lesions that get SHM and CSR underway (Conticello et 
al., 2007; Okazaki et al., 2003). Several lines of evidence showed that AID can bind and 
target single-stranded DNA (ssDNA), but not double-stranded DNA (dsDNA) or RNAs 
(Larijani et al., 2007a; Dickerson et al., 2003; Bransteitter et al., 2003). Previous work in 
the field showed that cytidines within trinucleotide WRC (W=A or T, R= A or G) motif 
are preferentially mutated by AID in vitro (Beale et al., 2004; Pham et al., 2003). This 
preferential mutating by the purified AID in vitro is consistent with the pattern of SHM in 
vivo (Larijani et al., 2005; Yang & Schatz, 2007). The ssDNA specificity of AID along 
with its preference for highly transcribed genes has led to the idea that transcription is a 
major source of ssDNA substrate for AID activity. It is thought that during the 
transcription of Ig genes, the DNA double helix of the Ig genes become temporarily 
unwound and single-stranded locally, generating ssDNA that AID can bind and mutate, 
causing the formation of a uracil-guanine mismatch (U:G) mismatch in the target DNA 
(Martin & Scharff, 2002; Li et al., 2002). This U:G mismatch can be recognized and 
processed by various DNA repair mechanisms such as mismatch repair (MMR) or base-
excision repair (BER) pathways (David et al., 2007; Fischer et al 2007; Guo-Min, 2008). 
These types of DNA repair processes are often error prone because they recruit error-
prone polymerases to fill in the gaps. As a result, the initial cytidine to uridine mutations 
mediated by AID can manifest in the full spectrum of point mutations (i.e. from any 
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nucleotide to any of the other three) at variable region genes (Li et al., 2004; Peled et al., 
2008; Neuberger et al., 2005).  
  Because of genomic instabilities induced by the mutagenic activity of AID, its 
expression must be firmly controlled under physiological conditions (Gonda et al., 2003; 
Okazaki et al., 2003; Babbage et al., 2006). However, recent studies indicated that AID is 
responsible for genomic instability, chromosomal translocations, and the development of 
some cancers (Robbiani et al., 2008; Mechtcheriakova et al., 2012; Feldhahn et al., 2007; 
Takai, et al., 2012). Although the mutagenic activities of AID are mostly directed to Ig 
genes, AID can also act on non-Ig genes (Pasqualucci et al., 2001; Liu et al., 2008; 
Colotta et al., 2009). This off-target activity of AID can cause mutations and 
chromosomal translocations that lead to B cell leukemias and lymphomas, including 
Burkitt’s lymphoma which is caused by recombination between the proto-oncogene c-
Myc and the IgH locus S region (Ramiro et al., 2006; Robbiani et al., 2008). This 
translocation puts the expression of the proto-oncogene under the control of the potent 
IgH enhancers, and results in constitutive and/or over expression of this gene. Mouse 
model studies have shown that AID can directly cause DSBs at the Ig locus and c-Myc 
breakpoints and that in the absence of AID, this translocation is not detectable in B cells 
(Ramiro et al., 2006; Dorsett et al., 2007; KuÈppers & Dalla-Favera, 2001). Another 
example of lymphoma-associated chromosomal translocations mediated by AID is the 
BCL-2-IgH translocation observed in follicular lymphomas. Also, the double stranded 
breaks initiated by AID in BCL6 and IRF4 loci can result in chromosomal translocations 
leading to transformation of normal mature B cells to diffuse large B cell lymphoma 
(DLBCL) and multiple myeloma (Greeve et al., 2003; Jankovic et al., 2010; Park, 2012; 
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Pasqualucci et al., 2001). In addition, recent studies have revealed that AID may be 
indelibly expressed in cells other than B lymphocytes, such as T cells and non-immune 
cells, where it may also mediate tumorigenesis (Park 2012; Komori et al., 2008). Factors 
such as microbial infections and pro-inflammatory cytokines in non-immune cells have 
been shown to induce AID expression (Okazaki et al., 2007; Komori et al., 2008; 
Grivennikov et al., 2010).  
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1.5 The AID/APOBECs family of cytidine deaminase enzymes 
AID belongs to the APOBEC (apolipoprotein B mRNA editing enzyme, catalytic 
polypeptide-like) family of cytidine deaminase enzymes. AID/APOBEC enzymes have in 
common the capability to deaminate cytidine to uridine, thereby introducing mutations 
within DNA or RNA. Members of this family in humans include: APOBEC1, APOBEC2, 
APOBEC3A, APOBEC3C, APOBEC3D, APOBEC3F, APOBEC3G, APOBEC3H, 
APOBEC4, and AID (Conticello et al., 2007; Conticello, 2008; Larijani & Martin, 2012). 
The first characterized family member was APOBEC1, an enzyme responsible for 
converting cytidine at position 6666 of the apolipoprotein B (ApoB) pre-mRNA to 
uridine, thus generating a premature stop condon and resulting in a truncated ApoB  
protein (Navaratnam et al.,1993a; Teng et al., 1993). It has been shown that both 
APOBEC3G and APOBEC3F play a crucial role in innate antiretroviral immunity by 
deaminating cytidines in the minus-sense-strand of retroviral genomic DNA, therefore 
restricting replication of these viruses (Chiu & Greene, 2008; Sheehy et al., 2002; Yu et 
al., 2004). An important characteristic of APOBEC3G, APOBEC3F, and AID is their 
preference to target the third cytidine within specific trinucleotide motifs (Sheehy et al., 
2002; Yu et al., 2004; Beale et al., 2004; Conticello et al., 2005; Conticello et al., 2007; 
Larijani & Martin, 2012). The specific sequences in which cytidine is preferentially 
targeted and deaminated by A3G, A3F, and AID comprise CCC, TTC, WRC (W= A or T, 
R= A or G), respectively (Pham et al., 2003; Larijani et al., 2005; Sohail et al., 2005; 
Conticello et al., 2005). The preferential targeting of the cytidine located within these 
particular motifs by A3G, A3F, and AID enzymes is an inherent feature that correlates 
qutie closely with the sequence specificity of these enzymes in vivo (Larijani et al., 2005; 
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Coker & Petersen, 2007; Pham et al., 2003). The exact physiological functions of other 
APOBEC family members such as APOBEC2 and APOBEC4 have not yet been 
elucidated (Liao et al., 1999; Anant et al., 2001). Previous studies on the AID/APOBEC 
family using phylogenetic sequence analysis have revealed that the ancestral family 
members are AID and APOBEC2 since these are the only members to date identified in 
the more evolutionarily distant cartilaginous and bony fish (Conticello, 2008; Conticello 
et al., 2005; Barreto & Magor, 2011; Pancer & Cooper, 2006; Larijani & Martin, 2012). 
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1. 6 Structural features and biochemical parameters of human AID 
Purification of an active and pure AID enzyme is a difficult procedure, largely 
because it is a highly positively charged molecule that forms non-specific associations 
with other proteins and also because its expression is inherently highly genotoxic to cells.  
For these reasons, the crystal structure of AID has not been solved yet. In the absence of 
an experimentally determined structure, various structural features of AID may be 
modeled based on comparing the primary and secondary structure of this enzyme with 
other solved APOBEC family members and other deaminases such as the bacterial tRNA 
adenosine deaminase (tadA) whose structures have been solved (Losey et al., 2006; 
Prochnow et al., 2007; Conticello, 2008; Larijani & Martin; 2012; Dancyger et al., 2012; 
Chen et al., 2008; Holden et al., 2008). Several putative regions of AID have been 
suggested, which are responsible for different functions (figure 4). Among the functional 
regions identified thus far are an APOBEC-like region and nuclear export signal (NES), 
Zn-coordinating region, and the N terminus with a putative nuclear localization signal 
(NLS) (Barreto & Magor, 2011; Larijani & Martin, 2012). The putative NLS as well as 
regions suggested to be important for dimerization and tetramerization are located within 
the N terminal half of AID, while the NES is located in the C-terminus region. Recent 
studies suggested that AID can shuttle between the cytoplasm and nucleus using its NLS, 
NES, and other hydrophobic amino acids of the C-terminal region (Patenaude et al., 2009; 
Ito et al., 2004; Barreto & Magor, 2011). The function of the APOBEC-like region has 
not yet been characterized. This region is located at positions 119-183 of the carboxyl 
terminal end, and was defined based on comparing the sequence alignment of AID to that 
of other APOBECs (Barreto & Magor, 2011). The putative catalytic region of AID has 
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also been identified. It is the Zn-coordinating region of the enzyme ranging from residue 
56 to 90 and responsible for the enzymatic activity (Conticello, 2008; Barreto & Magor, 
2011). This region contains the canonical Zn-coordinating H[A/V]E-x[24–36]–PCxxC 
motif. The two Cysteines (C) and the Histidine (H) within this motif coordinate a zinc 
cation to form the catalytic core of AID (Figure 5) (Conticello, 2008; Barreto & Magor, 
2011). The cytidine binds in this pocket (Larijani & Martin, 2012) and gets deaminated 
and converted to a uridine through a nucleophilic attack by an activated water molecule 
(coordinated via the zinc atom) on the ammonium group of the fourth carbon atom of the 
cytidine, while the nearby glutamate functions as a proton donor (Conticello, 2008; 
Abdouni et al., 2013). Also, two putative DNA binding grooves have been identified that 
pass over the catalytic pocket of AID (Dancyger et al., 2012; Larijani & Martin, 2012) 
each of them is about 6 Å in width. Since dsDNA is about 20 Å wide, the size of these 
grooves is large enough to accommodate only ssDNA but not dsDNA (Pham et al., 2003; 
Sohail et al., 2003; Larijani et al., 2007a). In addition, the high percentage of positively 
charged residues, such as Arginine (R) and Lysine (K), at the putative DNA-binding 
grooves, may further explain why AID has high affinity binding to negatively charged 
ssDNA (Larijani et al., 2007a).  
Previous work by our group has demonstrated that human AID has a number of 
unique enzymatic characteristics such as a very slow rate of deamination activity, 
requiring several minutes to perform 1 reaction (most other enzymes perform thousands 
of reactions/sec) (Larijani, et al., 2007). It has been suggested that the slow deamination 
rate of human AID and the unusual high affinity binding of ssDNA (nM range affinity for 
ssDNA) may be an intrinsic property of this enzyme to restrict and control its off-target 
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mutagenic activity in vivo and explain its apparent enzymatic processivity in vitro (Pham 
et al., 2007; Coker & Petersen-Mahrt, 2007; Larijani & Martin, 2012; Dancyger et al., 
2012) 
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(Modified from Chaudhuri & Frederick, 2004) 
Figure 4: A simplified schematic representation of the primary structure of AID. 
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Figure 4: A simplified schematic representation of the primary structure of AID. 
The primary structure of activation-induced cytidine deaminase (AID) is shown, 
depicting the nuclear-localization sequence (NLS) in the N terminus, nuclear-export 
sequence (NES) in the C terminus and the catalytic (Zn-coordinating) region between the 
N and the C terminal regions. The APOBEC1-like C terminal region is located at 
positions 119-183 of the carboxyl terminal region. 
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(Modified from Dancyger et al., 2012) 
Figure 5: Ribbon models of predicted structures of Hs-AID, Dr-AID, and Ip-AID. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
Figure 5: Ribbon models of predicted structures of Hs-AID, Dr-AID, and Ip-AID.                 
Ribbon models of the predicted monomer structures of human AID (Hs-AID), zebrafish 
AID (Ip-AID), and catfish AID (Ip-AID) were created based on the solved structure of 
the APOBEC3G catalytic region. N- to C-terminal progression is shown in color from 
blue to red. The blue-colored α-helix structure represents the N-terminal region, whereas 
the red-colored α-helix structure represents the C-terminal region. Putative catalytic (Zn-
coordinating) residues are shown in stick format in red. Putative position of the Zn cation 
is shown by a purple ball. 
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1.7 Biochemical features of AID orthologs compared to human AID  
AID is present in organisms as far back on the evolutionary scale as the earliest 
gnathostomes (jawed vertebrates) studied to date (Rogozin et al., 2007; Saunders et al., 
2010). Even though the 3-dimentional structure of AID is not known, the primary 
sequence of AID from mammals, amphibians, and birds is highly conserved implying that 
many structure-function features may also be shared. AID sequence has been identified 
from many different species including, human, mouse, rat, dog, cat, rabbit, duck, cow and 
chimpanzee (Barreto & Magor, 2011; Bascove & Frippiat, 2010; Zhao et al., 2005). The 
oldest living vertebrates for which AID structure-function relationships have been studied 
are bony fish. Since they are so distantly related, bony fish AIDs are the most divergent 
from their human counterpart (Conticello et al., 2005; Wakae et al., 2006; Barreto & 
Magor, 2011) and recent work from our lab has shown that they have altered biochemical 
characteristics (Dancyger et al., 2012; Abdouni et al., 2013). 
 It has been demonstrated that AID from various species have disparate 
deamination rates, and that the deamination rate of AID from each species is 
thermosensitive (temperature-dependent) and optimal at natural physiological 
temperatures, such that fish AID are cold-adapted (Dancyger et al., 2012). In general, the 
cold-adapted catalytic activity of fish AID is ascribed to increased ssDNA binding 
affinity at lower temperatures. In addition, zebrafish AID has a higher catalytic rate than 
human AID while catfish AID has the lowest overall level of activity. This discrepancy is 
mediated by a single amino acid difference in the C terminus (Dancyger et al., 2012). 
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1.8 Mechanisms of enzyme thermosensitivity 
Overall enzyme structure and function are significantly influenced by temperature. 
For proper enzyme function, a balance has to be maintained between flexibility and 
stability, particularly in regions which are required for catalysis. Changes in temperature 
tremendously interrupt this balance. Therefore, enzymes are often temperature-dependent 
in substrate binding and catalysis. Generally, as temperature increases over a specific 
range, an enzyme becomes highly flexible; disrupting the catalytic site and other regions 
which can possibly also diminish the enzyme-substrate binding affinity. If temperature is 
further increased, the enzyme will eventually denature. On other hand, the enzyme can be 
catalytically inactive and excessively rigid at cold temperatures, which lowers the 
catalytic efficiency of the enzyme beneath the level needed to maintain metabolic 
homeostasis within the cell (Jaenicke 1991; Fields et al., 2001; Fields, 2002; Zavodszky 
et al., 1998; Field & Houseman, 2004).  
Since different organisms have evolved in dissimilar thermal environments, their 
enzymes may have adapted to disparate temperature conditions. Therefore, enzyme 
thermosensitivity usually varies among unrelated species (Feller & Gerday, 2003; Smalas, 
2000; D’Amico et al., 2002; Somero, 2004; Siddiqui & Cavicchioli, 2006). Also, it has 
been shown that cold-adapted enzymes in general have distinct properties from warm-
adapted ones. On one hand, cold-adapted enzymes have evolved a variety of 
characteristic structural features that provide them with high flexibility at low 
temperatures. The high level of plasticity is mainly around the catalytic site of the cold-
adapted enzyme, which is usually associated with weak substrate binding affinity and 
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low-activation energy, but high specific activity at low temperatures (Siddiqui & 
Cavicchioli, 2006; Fields & Somero, 1998; D’Amico et al., 2002). On the other hand, 
warm-adapted enzymes (thermostable enzymes) are characterized by reduced activity and 
low structural flexibility at low temperature (Eijsink et al., 2004; Siddiqui & Cavicchioli, 
2006; Fields; D’Amico et al., 2002). Therefore, investigating the thermosensitivity 
characteristics of a given enzyme in detail can be a useful approach to gain more 
information about its structure. 
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1.9 Purpose of study: mapping the thermosensitivity of AID and characterizing 
mechanisms of thermosensitivity  
Rationale: 
Our lab has recently shown that human AID is more enzymatically active at 37°C, 
and has diminished enzymatic efficacy at low temperatures such as 25°C & 18°C. On the 
other hand, fish AIDs (e.g. zebrafish and channel catfish AID) are catalytically optimal at 
25°C, and exhibit lower activity levels at 37°C (Dancyger et al., 2012). Also, a previous 
study by Conticello and his group on non-mammalian AID has compared the enzymatic 
activity of the pufferfish (cold-adapted) AID to that of mouse (warm-adapted) AID using 
a bacterial rifampicin-rescue mutation assays (Conticello, et al., 2005). Their study 
revealed that at 37°C pufferfish AID has no noticeable deamination activity, but at 18°C 
this enzyme showed increased deamination activity level (Conticello et al., 2005; Barreto 
& Magor, 2011). In general, bony fish are categorized as poikilotherms (cold-
blooded), organisms whose internal body temperature varies according 
to the temperature of their surroundings. In contrast, mammals are homeothermic (warm-
blooded) organisms that maintain a constant internal body temperature regardless of 
environmental temperatures. Several earlier studies have shown that various species (e.g. 
cold- and warm-adapted organisms) that have evolved in different thermal environments 
have enzymes that are adapted to the distinct temperatures (Feller & Gerday, 2003; 
Smalas, 2000; D’Amico et al., 2002; Somero, 2004; Siddiqui & Cavicchioli, 2006). 
Generally speaking, there are significant differences between cold- and warm-adapted 
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enzymes in their overall structural flexibility, thermostability and substrate binding at 
certain temperatures (Feller & Gerday, 2003; Georlette et al., 2004).  
  The molecular basis of AID's cold- and warm-adaption has not yet been 
elucidated. In this study, we focused our research on better understanding AID 
thermosensitivity among various species. In particular, we conducted a comparative study 
to elucidate this characteristic of human AID versus the most divergent bony fish AIDs.  
1.10 Specific aims and hypothesis 
The specific goals of our research included: 
1) To precisely determine the optimal temperature and the thermosensitivity patterns for 
each AID enzyme. 
2) To identify and highlight the important structural region(s) responsible for 
thermosensitivity of AID. 
3) To quantitatively understand thermosensitivity by characterizing the degree of 
difference in enzyme velocity when measured at optimal and sub-optimal temperatures.   
To scrutinize the mechanism underlying thermosensitivity of AID and gain more 
insights into its structure-function relationships, we used a bacterial expression system to 
express and purify human, zebrafish, channel catfish, and pufferfish AIDs, along with 
hybrid AID enzymes made of different portions of the above mentioned enzymes. These 
hybrid AIDs were used to pinpoint and narrow down regions that can transfer this 
property of AID. All purified AID enzymes were examined over a wide range of 
temperatures to precisely determine the optimal temperatures and then thermosensitivity 
patterns of each AID enzyme. One possible model is that the thermosensitivity of AID is 
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a characteristic that is based in one continuous region of the enzyme and can be 
transferred from one species to another by swapping said region. Alternatively, this 
property might be attributed to the overall conformational structure of AID in a way that 
requires residues that are discontinuous in the primary structure, to function 
in combination. Our results suggest that the thermosensitivity of AID is mainly a C-
terminal region based feature, and swapping the N-terminal or the catalytic region of AID 
between species does not influence the thermosensitivity. Importantly, we also found that 
the optimal temperature for human AID in vitro is at 32°C rather than 37°C, which 
suggests that optimal temperature can be distinct form physiological temperature and 
provides clues on the evolution of AID. 
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2. Materials and Methods 
2.1 AID expression and purification of AID 
  The open reading frames (flanked by EcoRI recognition sequences) encoding 
zebrafish AID (Dr-AID), catfish AID (Ip-AID), and pufferfish AID (Tr-AID) were cloned 
into pGEX-5x-3 N-terminal GST-tag to create  GST-AID as previously described 
(Dancyger et al., 2012; Larijani et al., 2007; Saunders & Magor, 2004; Zhao et al., 2005; 
Ichikawa et al., 2006). We utilized EditSeq Software to design hybrid AID enzymes 
involving different AID regions from human and either zebrafish or channel catfish or 
pufferfish (takifugu) AIDs. Open reading frames for these hybrid AIDs were designed 
and synthesized (Genscript) and cloned into pGEX-5-3-GST expression vector by using 
EcoRI restriction sites in the same way as the original cloning for  human AID (GST-Hs 
AID), zebrafish AID (GST-Dr AID) and catfish AID (GST-Ip AID) (Dancyger et al., 
2012; Larijani et al., 2007; Abdouni et al., 2013). Constructs containing AID inserts were 
verified by restriction digests and sequencing. 1 g of each GST-AID plasmid DNA was 
mixed with 50 L of BL21 (DE3), chemically competent E. coli. The reaction was placed 
for 30 minutes on ice, then heat shocked for 90 seconds at 42°C in preheated water bath, 
and then 250 L of Super Optimal Broth (SOB medium) (2% Bacto-tryptone, 0.5% 
Bacto-yeast extract, 0.05% Sodium chloride, 2.5 mM KCl, and 10 mM MgCl2) was 
quickly added to each reaction tube. All the reaction tubes were incubated in a shaking 
incubator at 37°C for 1 hour. 100 L of each tube was plated on an LB plate with 
antibiotic (37g LB, agar, 1 litter of MilliQ dH2O, 100 g/ml ampicillin). All LB plates 
were inverted and incubated for 12-16 hours at 37°C. Glycerol stocks of bacteria were 
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frozen for future AID production and purification (glycerol stocks were maintained at -
80°C). AID expression was induced and GST-AID was purified using GST columns as 
previously described (Dancyger et al., 2012; Larijani et al., 2007). Briefly, one colony 
from each plate was picked (or cultures were started from frozen glycerol stocks) and 
grown in 250 ml LB medium plus 50 mg/ml Ampicillin at 37°C, 225 rpm until log phase 
was reached. 250 L of [1 M] IPTG (Isopropyl β-D-1-thiogalactopyranoside) as well as 
250 L of 50 mg/mL Ampicillin were added to induce AID expression in DE3 bacterial 
cells. Bacterial cultures were then incubated for 16 hours at 16°C. The next day, each 
culture was poured into 250 mL centrifuge bottles, and centrifuged for 10 minutes at 5000 
rpm, 4C. The supernatant was drained and pellets were resuspended in 20 mL of cold 1X 
PBS, then the resuspended pellets were transferred to labelled 50 mL Falcon tubes. Cells 
were lysed twice in a French pressure cell press (Thermospectronic), then transferred to 
50 mL centrifuge tubes and centrifuged at 4C, 5000 rpm for 10 minutes. After 
centrifugation, the supernatant was applied to a column of Glutathione-Sepharose beads 
(Amersham) as per the manufacturer’s instructions. The flow through was reapplied to 
the column, then the column was washed with 1X PBS. AID was eluted with elution 
buffer (50mM Tris pH 8.0, 100 mM reduced glutathione) as per the manufacturer’s 
recommendations. 15-20 fractions of 500 L of eluted GST-AID were aliquoted into 1.5 
ml tubes kept on ice. The optical density of each eluted fraction was measured using a 
NanoDrop to determine protein content. AID fractions with the highest concentrations 
which constitute the peak protein containing fractions were pooled and placed into sealed 
SnakeSkinⓇ
 
Pleated dialysis tubing and dialyzed overnight in 1 litter of dialysis Buffer 
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(20 mM Tris-Cl pH 7.5, 100 mM NaCl, 1 mM dithiotheritol (DTT). On the following 
day, the dialysis buffer was replaced, and the AID fractions were further dialyzed for 3-5 
hours.  Aliquots of 30-50 L of the dialysed AID were distributed into 1.5 ml tubes, flash 
frozen in liquid nitrogen and stored at -80°C for future use in enzyme assays. For each 
GST-AID enzymes, multiple independent purifications (2-4) were made. The purity of 
each purified GST-AID protein was assessed by SDS-PAGE. We then investigated the 
optimal temperature of each hybrid AID in parallel with the purified wild type AID from 
human and bony fish, over a wide range and fine increments of temperatures. 
 
2.2 AID substrate: preparation and labelling 
Generation of a bubble substrate as a target for AID deamination has been 
previously described (Larijani & Martin, 2007). Briefly, this substrate is 56 nt in length 
and comprises a 7 nt long single-stranded bubble region that has cytidine (C) within the 
hotspot motif WRC (WRC motifs W=A/T, R=purine (A/G), C=cytidine). The top strand 
of the substrate (BHagtop) was purified by desalting, whereas the bottom strand 
containing the hot spot motif WRC (TGCbub7, AGCbub7, TACbub7) was purified by 
High Performance Liquid Chromatography (HPLC). 
The top strand (BHagtop) 
5’–AGA TCC TGC CCC GGC ACT TCG CCC GGG TTT TTC CAG TCC CTT CCC 
GCT TCA GTG AC– 3’ 
The bottom strand TGCbub7 
5’–GTC ACT GAA GCG GGA AGG GAC TGT GTGC*TT CCG GGC GAA GTG 
CCG GGG CAG GAT CT– 3’ 
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The bottom strand TACbub7 
5’–GTC ACT GAA GCG GGA AGG GAC TGT GTAC*TT CCG GGC GAA GTG 
CCG GGG CAG GAT CT– 3’ 
The bottom strand AGCbub7 
5’–GTC ACT GAA GCG GGA AGG GAC TGT GAGC*TT CCG GGC GAA GTG 
CCG GGG CAG GAT CT– 3’ 
Each 1 L of 2.5 pmol of the bottom strand (target strand) was labelled with 3 μL 
of 15 μCi/μL Adenosine 5′-triphosphate, ATP-[γ-32P] at the 5′-end using 1 L of 
polynucleotide kinase (PNK) (NEB, Ipswich, MA, USA), 4 L of autoclaved MilliQ 
dH2O, and 1 L of 10XPNK buffer. The reaction was mixed well and incubated for 1 
hour at 37C, then at 65C for 10 minutes to deactivate the PNK enzyme. The reaction 
was briefly centrifuged, 10 μL of 1X Tris-EDTA (TE) buffer was mixed with the 
reaction, and then the 20 L reaction was added to a mini-Quick spin DNA column 
(Roche) and spun at 3000 rpm for 3 minutes to separate and remove any unlabelled 
substrate. 5 μL 1 M KCl, 3 μL 2.5 pmol/μL BHagtop top strand (complementary strand) 
were added to the resulting flow through to form the bubble substrate. The final volume 
was adjusted to 50 μL by adding autoclaved MilliQ water. This mixture was incubated for 
2 minutes at 96 C, and then the temperature of the incubation was decreased by 1°C 
every 30 seconds until the temperature reached 4°C. The labelled bubble substrate was 
then stored at -20°C.  
2.3 Alkaline cleavage deamination assay 
 This assay has already been described (Sohail et al., 2003; Larijani et al., 2007; 
Dancyger et al., 2012) and was used to measure and quantify the catalytic activity of AID. 
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A schematic representation of the alkaline cleavage deamination assay is shown in figure 
6. The deamination activity of AID was tested over a wide range of temperatures in order 
to precisely determine the optimal temperatures and thermosensitivity patterns of each 
wild type AID along with the hybrid AID enzymes. Briefly, 0.15-300 fmol/L of the 
labelled bubble substrate was incubated with 0.1-0.25 μg GST-AID enzymes (to 
deaminate the cytidine within the hot spot motif WRC) in 100 mM phosphate buffer pH 
7.3 in a total volume of 10μL per reaction tube, over a broad range and fine increments of 
temperatures. Negative controls were reactions with substrate and no enzymes, and 
positive controls were reactions containing enzymes previously purified and known to be 
active. The incubation time ranged from 2 to 6 hours followed by immediate increase in 
the temperature to 85°C for 30 minutes (then returned to 37°C for 10 min) to irreversibly 
deactivate AID so as to ensure that each AID enzyme was incubated only at the intended 
temperature before moving on to the next step which takes place at 37°C.  A master mix 
of 7.8 μL H2O, 2 μL 10X UDG buffer and 0.2 μL UDG enzymes (NEB, Ipswich, MA, 
USA) was incubated with the previous reaction for 30 minutes to excise the uridine. The 
total reaction volume is now 20 ul. 2 l of 2 M NaOH (fresh; 200 mM final) was then 
added and temperature was increased to 96°C for 10 minutes to cleave the alkali-labile 
abasic site. Immediately before loading the gel, 8 L of formaldehyde loading dye were 
added to each reaction and incubated at 96°C for 5 minutes. Samples were loaded on a 
14% polyacrylamide denaturing gel (1X TBE, 25% Formamide, 14% 
acrylamide:bisacrylamide [19:1], 7M Urea) and run at 200-300 V until dye front travelled 
approximately halfway down the gel. The resolved gels were exposed to a blanked Kodak 
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Storage Phosphor Screen GP (Bio-Rad) and imaged using a PhosphorImager (Bio-Rad, 
Hercules, CA, USA). Quantitation was done using an Image Lab™ 4.1 and Quantity One 
1-D Analysis Software (Bio-Rad, Hercules, CA).  
2.4 Data collection, quantification and analysis 
Image Lab™ 4.1 analysis Software (Bio-Rad) was used to measure and compare 
the densitometry of the deaminated product band and the substrate band.  Using these 
values, the relative amount of deaminated product (as a percentage of the total non-
deaminated and deaminated bands) was derived. Background values are automatically 
determined by Image Lab, and were also manually determined from negative control 
lanes and subtracted from reaction lanes.  For independent confirmation, each individual 
lane of an alkaline cleavage was also quantified three times using Quantity One 1-D 
Analysis software (Bio-Rad, Hercules, CA) to ensure the accuracy of data analysis. 
Experiments were repeated at least 2 and up to 6 times to ensure reproducibility of results. 
GraphPad Prism software (GraphPad, San Diego, CA, USA) was used to graph and 
analyze the obtained data. 
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(Figure A was modified from Abdouni et al., 2013) 
Figure 6: Schematic representation of alkaline cleavage deamination assay. 
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Figure 6: Schematic representation of alkaline cleavage deamination assay. 
A) Typical TGC bubble substrate used in the in vitro alkaline cleavage deamination 
assay. The red C within the hot spot motif TGC indicates the target cytidine. Asterisk (*) 
indicates the radioactively labeled strand. During the alkaline cleavage assay, AID 
deaminates the cytidine within the TGC motif turning it into uridine. The uridine is then 
excised by the addition of UDG enzyme producing an abasic site that is alkali-labile. This 
alkali-labile abasic site can be cleaved by adding NaOH to generate a cleaved product. By 
measuring and comparing the quantity of the cleaved product versus the non-cleaved 
substrate, we can precisely measure the deamination activity and then identify the 
thermosensitivity pattern of each AID enzyme. B) A result of alkaline cleavage assay 
showing the deamination activity of Human AID on TGCbub7 substrate versus the 
negative control sample (substrate without adding AID).  
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3. Results 
3.1 Human AID has a distinct thermosensitivity and adaptive temperature from 
bony fish AIDs, but neither the catalytic nor N-terminal region of AID plays a 
significant role in these adaptive changes  
Our lab recently showed that AID from various species have disparate catalytic 
efficiencies (deamination rates), and that the catalytic efficiency of AID from each 
species is “optimal” at natural physiological temperatures and is diminished at other 
temperatures (Dancyger et al., 2012). Specifically, when tested at three different 
temperatures, human AID displayed “optimal” deamination activity at 37°C compared to 
25°C and 18°C, respectively. In contrast, bony fish AIDs (e.g. zebrafish AID, and catfish 
AID) exhibited reduced deamination rates at 37°C, but increased activities at 25°C and 
18°C. However, the molecular basis and the underlying causes of the thermosensitivity of 
AID among various species are not known. Since the structure of AID has not yet been 
elucidated, we hypothesized that understanding this biochemical property can potentially 
reveal novel structure-function aspects. We proceeded to test our specific hypothesis that 
the thermosensitivity of AID is a characteristic encoded within a specific region of the 
enzyme, which can be transferred from one species’ AID to another by swapping said 
region. Alternatively, this property might be attributed to the overall 3-dimensional 
structure of AID in a way that requires residues located throughout the enzyme rather 
than a region that is continuous in the primary structure. To test this hypothesis, the 
primary structure of AID was divided into three linear regions based on the position of 
the catalytic region (the region that contains the Zn-coordinating residues) and the 
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basic similarity of AID to other APOBEC family members. We defined the three linear 
regions of AID as the N-terminal, the catalytic (Zn-coordinating), and the C-terminal 
(figure 7). Hybrid AID enzymes involving portion(s) from human AID swapped with 
other AID portion(s) from either zebrafish or channel catfish or takifugu AID were 
constructed in order to narrow down and identify which region of AID is specifically 
responsible for this biochemical property. The three letter description of each hybrid 
denotes the N-, catalytic, and carboxyl-terminal regions, respectively. Our hybrid AID 
enzymes were designed as follows: HDH and HIH AIDs are human AIDs (Hs-AID) with 
the catalytic regions of zebrafish AID (Dr-AID) and catfish AID (Ip-AID), respectively; 
HII AID is an Ip-AID with the N-terminal region of Hs-AID. These hybrid AIDs along 
with the aforementioned wild-type AID enzymes were independently cloned into our 
GST-fusion pGEX-5-3 expression vectors, expressed in E.coli and purified on 
Glutathione agarose beads to produce GST-tagged AID as previously described (Larijani 
et al., 2007). SDS PAGE was utilized to determine the purity of each AID enzyme used in 
the following experiments. The deamination rate and the thermosensitivity of each 
purified AID were tested using the alkaline cleavage assay. In this approach, each 
purified AID was incubated with radioactively labeled DNA substrate that has the AID-
favored hot spot motif TGC within partially single-stranded bubble sequences (figure 9). 
This bubble substrate with 7 nt long was shown to be an optimal target for AID 
deamination (Larijani et al., 2007). The incubation was carried out at three different 
temperatures 37°C, which is the normal human body temperature; 25°C and 18°C, which 
represent a range of temperatures where some bony fish (e.g. Zebrafish and channel 
catfish) naturally live (Shrable et al., 1969; Chen 1976; Spence et al., 2006). During 
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incubation, AID deaminates the cytidine within the TGC motif turning it into uridine. The 
uridine is then excised by the addition of UDG enzyme producing an abasic site that is 
alkali-labile (Larijani & Martin, 2007). NaOH is then added to cleave the alkali-labile 
abasic site generating a cleaved product (figure 6). By measuring and comparing the 
quantity of the cleaved product versus the non-cleaved substrate, we can precisely 
measure the deamination activity and then identify the thermosensitivity pattern of each 
AID enzyme. As expected, Dr-AID and Ip-AID demonstrated higher deamination rates at 
25°C than at 37°C (in average of 6 experiments: Dr-AID 59% at 18°C, 69% at 25°C, and 
26% at 37°C; Ip-AID 11% at 18°C, 17% at 25°C, and 4% at 37°C), whereas Hs-AID was 
more catalytically active at 37°C than at 25°C and 18°C (in average of 6 experiments: 
39% at 37°C vs. 21%, 14% at 25°C and 18°C, respectively). Both Dr-AID and Ip-AID 
(regardless of the difference in their activity levels) exhibit the same general trend of 
thermosensitivity in that they have diminished deamination rate at 37°C and maximum 
activity at 25°C (figure 10). Quite surprisingly, both HDH and HIH hybrid AIDs have 
enhanced catalytic rates at 37°C rather than at lower temperatures (In average of 6 
experiments: HDH 17% at 37°C vs.  9%, 7% at 25°C and 18°C, respectively; HIH 25% at 
37°C vs. 21%, 19% at 25°C and 18°C, respectively), and each of them displayed the same 
thermosensitive modality as Hs-AID (figure 11-A). In contrast, the HII hybrid AID 
enzyme revealed similar thermosensitivity pattern to Ip-AID (figure 11-B). We noticed 
that even though the catalytic region of Hs-AID was swapped once with that of Dr-AID 
(e.g. HDH) and with Ip-AID (e.g. HIH), this exchange does not seem to have an effect on 
the thermosensitivity pattern of Hs-AID. In addition, interchanging the N-terminal end of 
the catfish AID with its equivalent of human AID (e.g. HII) does not transfer the 
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thermosensitivity from the latter to the former. Therefore, we concluded that neither the 
catalytic nor the N-terminal region of AID seems to play a noteworthy role in influencing 
the thermosensitivity of AID from human and bony fish.  
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Figure 7: Amino acid sequence alignment of human versus bony fish AID. 
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Figure 7: Amino acid sequence alignment of human versus bony fish AID. 
Amino acid sequences of human AID were compared with their equivalents sequences of 
zebrafish, catfish, and takifugu AIDs. Hs-AID, Dr-AID, Ip-AID, and Tr-AID stand for 
human, zebrafish, catfish, and pufferfish (takifugu) AIDs, respectively. Residues are 
colored according to the side chain. Blue underlining indicates identical residues, green 
indicates similar residues, and red indicates disparate residues. The boundaries of the 
carboxyl, catalytic, and N-terminal regions are indicated by the arrows. These amino acid 
sequences are obtained from the published sequences of AID (Homo sapien: AA95406.1 
for human AID, Danio rerio: NP001008403 for zebrafish AID, Ictalurus punctatus: 
AAR7544 for catfish AID, Takifugu rebripes: AAU95747 for pufferfish AID), and 
aligned using Strap Alignment software (http://www.bioinformatics.org/strap/).  
 
 
 
46 
 
 
Figure 8: Schematic representation of hybrid AID enzymes. 
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Figure 8: Schematic representation of hybrid AID enzymes. 
Hybrid AID enzymes involving different region(s) from human AID linked with other 
AID region(s) from either zebrafish or catfish or takifugu AIDs. These hybrid AID 
enzymes were designed and constructed in order to determine which hybrid AID with an 
altered thermosensitivity and specify which region would transfer the thermosensitivity 
from one species to another. The three letter description of each hybrid AID indicates the 
N-, catalytic and carboxyl-terminus regions, respectively. The green, red, yellow, and 
blue bars denote Human, zebrafish, catfish, and takifugu AIDs, respectively. 
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Figure 9: Partially single-stranded bubble substrate used in alkaline cleavage 
deamination assay. 
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Figure 9: Partially single-stranded bubble substrate used in alkaline cleavage 
deamination assay. 
Radioactively labeled DNA substrate with 56 nt in length containing a 7 nt long single-
stranded bubble region that has hot spot motif TGC for AID deamination. During the 
alkaline cleavage assay, AID deaminates the cytidine nucleotide located within TGC 
motif to uridine. The targeted cytidine is colored in red and the radioactively labeled 
strand is denoted by (*). 
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Figure 10: Comparison of thermosensitivity patterns of Hs-AID Dr-AID, and Ip-
AID at three different temperatures. 
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Figure 10: Comparison of thermosensitivity patterns of Hs-AID Dr-AID, and Ip-
AID at three different temperatures. 
The thermosensitivity pattern of human AID was compared with zebrafish and catfish 
AIDs at 37°C, 25°C, and 18°C. Each AID enzyme was incubated for 2 hours with 50 
fmol of TGCbub7 substrate. The quantity of the deamination by each AID at each 
temperature was measured using Image Lab™ 4.1 software and confirmed by Quantity 
One 1-D analysis software. The percentage of the deaminated products was plotted.  Dr-
AID and Ip-AID exhibited different levels of deamination; nevertheless they have 
comparable thermosensitivity patterns. Both of Dr-AID and Ip-AID (regardless of the 
difference in their activity levels) have maximum activity at 25°C, whereas the enzymatic 
activity of Hs-AID declined as temperature was reduced.   
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Figure 11: Comparison of thermosensitivity patterns of HDH, HIH, and HII at three 
different temperatures. 
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Figure 11: Comparison of thermosensitivity patterns of HDH, HIH, and HII at three 
different temperatures. 
The thermosensitivity patterns of the hybrid AID enzymes: HDH, HIH (figure 10-A), and 
HII (figure 10-B) at 37°C, 25°C, and 18°C were compared. Both HDH and HIH are Hs-
AIDs with catalytic region of Dr-AID and Ip-AID, respectively. HII is a Ip-AID with N-
terminal region of Hs-AID. Each of these hybrid AID enzymes was incubated for 2 hours 
with 50 fmol of TGCbub7 substrate. Hs-AID, Dr-AID, and Ip-AID were used as positive 
controls in this experiment, but were represented in a separate graph. The amount of the 
deamination by each hybrid AID at each temperature was measured using Image Lab™ 
4.1 software and confirmed by Quantity One 1-D analysis software. The percentage of the 
deaminated products was plotted. HDH and HIH AIDs displayed comparable 
thermosensitivity patterns to that of Hs-AID, whereas the thermosensitivity pattern of HII 
AID was equivalent to that Ip-AID. 
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3.2 AID activity is not always optimal at native physiological temperatures 
Even though testing the wild type AIDs (Hs-AID, Dr-AID, and Ip-AID) at three 
different temperatures substantiated the idea that AID from various species have disparate 
thermosensitivity patterns, the exact optimal temperature for each AID enzyme was still 
unknown. For that reason, the wild type AIDs were examined over a wider range and 
smaller increments of temperatures to more precisely determine the optimal temperature 
conditions for each AID enzyme. Initially, Hs-AID, Dr-AID, and Ip-AID were each tested 
at 12°C, 14°C, 16°C, 18°C, 20°C, 22°C, 25°C, 27°C, 30°C, 32°C, 34°C, 37°C, 39°C, and 
41°C. Intriguingly, the optimal temperature for Hs-AID in vitro was not 37°C as formerly 
assumed; instead, in average of 5 independent experiments, Hs-AID was 1.6 fold more 
catalytically active at 32°C than at 37°C, whereas the precise optimal temperatures for 
Dr-AID and Ip-AID was 27°C and 22°C, respectively (figure 12). This finding enabled us 
to more precisely define whether a hybrid AID is more similar to human or fish in terms 
of its thermosensitivity. Specifically, we set the definition that regardless of the absolute 
activity level compared to other enzymes, if a hybrid AID was optimal at 25°C (+/- 2°C) 
then it will be categorized "fish-like" in its thermosensitivity. If on the other hand the 
hybrid AID was optimal at 32°C (+/- 2°C), then it will be categorized as "human-like" or  
warm-adapted.   
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Figure 12: Comparison of optimal temperatures and thermosensitivity patterns of 
Hs-AID, Dr-AID, and Ip-AID over a wide range of temperatures. 
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Figure 12: Comparison of optimal temperatures and thermosensitivity patterns of 
Hs-AID, Dr-AID, and Ip-AID over a wide range of temperatures. 
The deamination activities and thermosensitivity patterns of Hs-AID, Dr-AID, and Ip-
AID were compared over a wide range and small increments of temperature from 12°C to 
41°C.  The optimal temperatures for each of these AID enzymes were determined and 
plotted. 50 fmol of TGCbub7 substrate was incubated with each AID for 2 hours at 12°C, 
14°C, 16°C, 18°C, 20°C, 22°C, 25°C, 27°C, 30°C, 32°C, 34°C, 37°C, 39°C, and 41°C. 
The reaction temperature was immediately increased to 85°C for 30 minutes (then 
decreased to 37°C for 10 minutes) to irreversibly deactivate AID and so as to ensure that 
each AID enzyme was incubated only at our intended temperature before moving on to 
the next step which takes place at 37°C. The percentage of the each deaminated product 
was plotted. The optimal temperature for Hs-AID is 32°C, whereas Dr-AID and Ip-AID 
are optimal at 27°C and 22°C, respectively. 
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3.3 Optimal temperatures of hybrid AID enzymes. 
 Following our approach of precisely determining the optimal temperatures of each 
AID enzyme using finer increments, more hybrid AID enzymes were designed (figure 8), 
and tested over a wide range of temperatures in order to identify the optimal temperature 
for each hybrid AID. In addition, we endeavoured to determine which region specifically 
is responsible for the thermosensitivity of AID. Different regions from human AID were 
pieced together with other region(s) from either the zebrafish or takifugu AIDs as 
following: DHH, THH, HDD and DDH AID. We utilized the N-terminal region from Tr-
AID (as another bony fish AID) and swapped it with the catalytic and the C-terminal 
region of Hs-AID to generate THH AID. This newly constructed hybrid AID was used to 
further confirm our conclusion up to this point, that the N-terminal region has no major 
role in influencing the thermosensitivity of AID.  Because this was our first analysis of 
Tr-AID and we did not know its sequence preference, we chose to test it on 3 different 
WRC motif-containing substrates: TGCbub7, AGCbub7 and TACbub7. Despite the fact 
that Tr-AID exhibited very low deamination activity in vitro, we found that it has the 
same general thermosensitivity pattern as Dr-AID and Ip-AID and also more preference 
for the TGCbub7 substrate than AGCbub7 and TACbub7 substrates, respectively (figure 
13). In agreement with our previous findings, both HDH and HIH hybrid AIDs 
demonstrated comparable optimal temperatures and thermosensitivity patterns to that of 
Hs-AID when they were tested at various temperatures ranging from 12°C to 41°C (30°C 
and 32°C were the optimal temperatures for HIH, HDH, respectively, vs. 32°C for Hs-
AID) (figure 14). This result confirmed that the catalytic region of AID has no significant 
effect on determining the thermosensitivity pattern. On the other hand, HII AID displayed 
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low catalytic efficiency, but nevertheless exhibited a thermosensitivity pattern identical to 
that of Ip-AID (22°C is the optimal temperature for HII vs. 22°C for Ip-AID) (figure 15). 
In addition, four independent preparations of THH and DHH (THH2, THH8, DHH2, and 
DHH7) were tested independently at different temperatures ranging from 12°C to 41°C. 
None of THH and DHH hybrid AIDs showed a disparate thermosensitive pattern from 
Hs-AID (figure 16), although the N-terminus of each of these hybrid AIDs does not 
belong to human AID (the optimal temperature was 30°C for DHH2, 31°C for DHH7, 
33°C for THH2, and 32°C for THH8 vs. 32°C for Hs-AID). These observations further 
strengthened our conclusion thus far that the N-terminus is inconsequential for 
thermosensitivity. Moreover, in confirmation of our previous results, HDD hybrid AIDs 
(HDD8 & HDD9) exhibited optimal temperatures and thermosensitivity patterns 
corresponding to Dr-AID; notwithstanding that they have the N-terminus of human AID 
(28°C and 26°C for HDD8 and HDD9 vs. 27°C for Dr-AID) (figure 17). In summary, all 
our data up to now endorse the notion that the N-terminal and the catalytic region of AID 
do not transfer the thermosensitivity pattern of AID from human to bony fish or vice 
versa.    
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Figure 13: Temperature and substrate preference of Tr-AID. 
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Figure 13: Temperature and substrate preference of Tr-AID. 
The deamination activity of takifugu AID (Tr-AID) was tested at three different 
temperatures (37°C, 25°C, and 18°C) on three different substrates (TGCbub7, AGCbub7, 
and TACbub7). 50 fmol of each substrate was incubated with Tr-AID for 6 hours. Since 
this purified Tr-AID has low enzymatic activity in vitro, the incubation time was 
increased from 2 to 6 hours. The amounts of the deaminated products produced by Tr-
AID at each temperature with each substrate were plotted.  TGCbub7 is the optimal target 
substrate for deamination in vitro by Tr-AID. Image Lab™ 4.1 software and Quantity 
One 1-D analysis software programs were used to measure the quantity of the 
deamination activity generated by Tr-AID. 
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Figure 14: Comparison of thermosensitivity patterns and optimal temperatures of 
HDH and HIH hybrid AIDs. 
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Figure 14: Comparison of thermosensitivity patterns and optimal temperatures of 
HDH and HIH hybrid AIDs. 
The optimal temperatures and thermosensitivity patterns of HDH and HIH AIDs were 
compared over a wide range and fine increments of temperature from 12°C to 41°C. 50 
fmol of TGCbub7 substrate was incubated with each of the hybrid AIDs for 2 hours at 
12°C, 14°C, 16°C, 18°C, 20°C, 22°C, 25°C, 27°C, 30°C, 32°C, 34°C, 37°C, 39°C, and 
41°C. The optimal temperatures for HDH and HIH AIDs were determined (32°C for of 
HDH vs. 30°C for HIH). The percentage of the deaminated products plotted.  
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Figure 15: The thermosensitivity pattern and optimal temperature of HII hybrid 
AID. 
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Figure 15: The thermosensitivity pattern and optimal temperature of HII hybrid 
AID. 
The deamination activity of HII hybrid AID was measured at temperatures ranging from 
12°C to 41°C. 50 fmol of TGC substrate was incubated for 2 hours with HII AID at 12°C, 
14°C, 16°C, 18°C, 20°C, 22°C, 25°C, 27°C, 30°C, 32°C, 34°C, 37°C, 39°C, and 41°C. 
The percentage of the deaminated products by HII at each temperature was plotted. The 
overall thermosensitivity pattern as well as the optimal temperature of HII was 
determined and illustrated. The optimal temperature of HII is identical with that of catfish 
AID (22°C is the optimal temperature for HII vs. 22°C for Ip-AID). 
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Figure 16: Comparison of optimal temperatures and thermosensitivity patterns of 
four independent preparations of THH and DHH hybrid AIDs. 
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Figure 16: Comparison of optimal temperatures and thermosensitivity patterns of 
four independent preparations of THH and DHH hybrid AIDs. 
Each of the four independent preparations of THH and DHH (THH2, THH8, DHH2, and 
DHH7) was tested on TGCbub7 substrate for 2 hours at 12°C, 14°C, 16°C, 18°C, 20°C, 
22°C, 25°C, 27°C, 30°C, 32°C, 34°C, 37°C, 39°C, and 41°C. Regardless of the disparate 
levels of the deamination activity generated by each of these hybrid AIDs, the optimal 
temperatures for all of them were consistent with that of Hs-AID (30°C for DHH2, 31°C 
for DHH7, 33°C for THH2, and 32°C for THH8 vs. 32°C for Hs-AID). The percentage of 
the deaminated products was graphed and the overall thermosensitivity pattern for each 
independent AID preparation was presented.   
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Figure 17: Comparison of optimal temperatures and thermosensitivity patterns of 
two independent preparations of HDD hybrid AID (HDD8 & HDD9). 
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Figure 17: Comparison of optimal temperatures and thermosensitivity patterns of 
two independent preparations of HDD hybrid AID (HDD8 & HDD9). 
The thermosenitivity patterns of two independent preparations of HDD (HDD8, HDD9) 
were compared. Each of the HDD preparations was incubated with 50 fmol of TGCbub7 
substrate for 2 hours at 12°C, 14°C, 16°C, 18°C, 20°C, 22°C, 25°C, 27°C, 30°C, 32°C, 
34°C, 37°C, 39°C, and 41°C.The percentage of the deaminated products by HDD8 and 
HDD9 AIDs at each temperature was plotted and the thermosensitivity patterns for both 
of them were graphed.  The optimal temperatures of HDD8 and HDD9 are similar to that 
of Dr-AID (28°C and 26°C for HDD8 and HDD9 vs. 27°C for Dr-AID). 
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3.4 The C-terminal region plays an important role in the thermosensitivity of AID  
 After excluding the possibility of significant roles of the N-terminal and catalytic 
regions in influencing AID thermosensitivity, our attention was drawn to the C-terminal 
region of AID. At that point, four independent preparations of DDH hybrid AID (DDH5, 
DDH6, DDH6’, and DDH9) were purified (as already described) and tested along with 
the previously constructed hybrid AIDs over a wide range of temperatures ranges from 
12°C to 41°C. Wild-type Hs-AID and Dr-AID were used as controls in this experiment. 
Although the four independent preparations of DDH AID displayed various levels of the 
deamination activity (which might be attributed to varying purification and expression 
conditions), they exhibited near identical thermosensitivity patterns closer to that of Hs-
AID (31°C for DDH5, DDH6, 30°C for DDH6’and DDH9 vs. 32°C for Hs-AID) (figure 
18). From this data, and previous work excluding the N- and catalytic regions, we 
conclude that the C-terminal region is the most significant part of AID in terms of 
containing the residue(s) that is/are responsible for thermosensitivity of AID. It is worth 
mentioning that the same conclusion can be drawn if particular attention was paid to the 
C-terminal end of any of our hybrid AIDs. In other words, we noticed that all the hybrid 
AID enzymes that have the C-terminal region of human AID, regardless of the origin of 
the N-terminal and catalytic regions (e.g. HDH, HIH, THH, DHH, and DDH), 
demonstrated thermosensitivity patterns and optimal temperatures similar to that of Hs-
AID (32°C, 30°C, 32°C, 31°C and 31°C for HDH, HIH, THH, DHH, and DDH, 
respectively, vs. 32°C for Hs-AID) (figure 11-A, 14, 16, and 18). In contrast, the hybrid 
AIDs that have a C-terminal region which belongs to Dr-AID (e.g. HDD) or Ip-AID (e.g. 
HII) exhibited thermosensitivity patterns and optimal temperatures paralleling those of 
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Dr-AID and Ip-AID, respectively (28°C and 26°C for HDD8 and HDD9, respectively, vs. 
27°C for Dr-AID;  22°C for HII vs. 22°C for Ip-AID) (figure 11-B, 15, and 17). To date, 
all our findings support the notion that the thermosensitivity of AID is mostly a C-
terminal region-based characteristic.  
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Figure 18: Comparison of optimal temperatures and thermosensitivity patterns of 
four independent preparations of DDH hybrid AID. 
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Figure 18: Comparison of optimal temperatures and thermosensitivity patterns of 
four independent preparations of DDH hybrid AID. 
Each of the four independent preparations of DDH was incubated with 50 fmol of 
TGCbub7 substrate for 2 hours at 12°C, 14°C, 16°C, 18°C, 20°C, 22°C, 25°C, 27°C, 
30°C, 32°C, 34°C, 37°C, 39°C, and 41°C. The percentage of the deaminated products at 
each temperature was plotted and the overall thermosensitivity patterns of DDH5, DDH6, 
DDH6’ and DDH9 were graphed. Regardless of the different levels of the deamination 
activity of each preparation of DDH, the optimal temperatures for all of them were 
comparable with that of Hs-AID (31°C for DDH5, DDH6, 30°C for DDH6’and DDH9 vs. 
32°C for Hs-AID). Image Lab™ 4.1 software and Quantity One 1-D analysis software 
programs were used to measure the quantity of the deamination activity generated by 
each AID enzyme. 
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3.5 Comparison of deamination kinetics of human AID at 32°C versus 37°C, and 
that of zebrafish AID at different temperatures 
 Since 37°C is the physiological human body temperature, most of the previously 
conducted studies on human AID were performed at this temperature. However, our 
recent findings provided convincing evidence that the optimal temperature in vitro for 
human AID to deaminate the cytidine in the hot spot motif TGCbub7 is 32°C instead of 
37°C (the deamination activity of Hs-AID was 33% at 32°C vs. 19% at 37°C) (figure 12). 
In contrast, we showed that the optimal temperature for Dr-AID in vitro is 27°C.  
Previous experiments were carried out with a single concentration of enzyme and 
substrate and a single incubation time, which does not allow for evaluation of true 
enzyme velocity. Thus, to quantitatively evaluate the extent of enzyme velocity 
differences at optimal vs. sub-optimal temperatures, we measured the deamination 
kinetics of each of Hs-AID and Dr-AID at these temperatures. We reasoned that this 
would also serve to further confirm our previous findings. To this end, we tested the 
deamination kinetics and the enzymatic activity of Hs-AID on TGCbub7 substrate at 
32°C, 37°C, and 41.5°C, whereas Dr-AID was tested at 16°C, 27°C, and 33°C. These 
different temperatures were particularly chosen to test Dr-AID, based on recorded 
observations of the natural water temperatures that ranged from 16.5°C to 33°C from nine 
different sites at which zebrafish were collected (Spence et al., 2006) and because our 
own work described above determined that the optimal temperature for zebrafish was 
27°C. 
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 The velocity of the reactions was measured as a function of substrate 
concentration over a 120 fold dilution range (0.25-30 nM). In agreement with our 
previous results, Hs-AID exhibited more robust enzymatic potential and greater velocity 
of product formation at 32°C than 37°C and 41°C (the greatest reaction velocities at 
32°C, 37°C, and 41°C were 0.195, 0.099, and 0.024 fmol product/gAID/min, 
respectively, at the point of maximal difference) (figure 19). On the other hand, the 
deamination kinetics of Dr-AID was tested on the same substrate (TGCbub7) at 16°C, 
27°C, and 33°C. Consistent with what we found thus far, Dr-AID reached the highest 
velocity of product formation at 27°C (the greatest reaction velocities at 16°C, 27°C, and 
31°C were 0.60, 1.30, and 0.66 fmol product/gAID/min, respectively, at the point of 
maximal difference) (figure 20). In conclusion, measuring the deamination kinetics of Hs-
AID and Dr-AID revealed that the optimal temperature for maximal enzyme velocity is 
32°C and 27°C for Hs-AID and Dr-AID, respectively. Furthermore, as expected from 
previous work (Dancyger et al., 2012; Larijani & Martin, 2012), under their optimal 
temperature conditions, Dr-AID demonstrated more potent deamination efficiency than 
Hs-AID (45 vs. 33%) (figure 12). 
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Figure 19: Comparison of deamination kinetics of Hs-AID at three different 
temperatures. 
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Figure 19: Comparison of deamination kinetics of Hs-AID at three different 
temperatures. 
The deamination kinetics of Hs-AID on TGCbub7 substrate was compared at 32°C, 37°C, 
and 41°C. The velocity of the reactions was measured as a function of substrate 
concentration over a 120 fold dilution range (0.25-30 nM). The velocity of AID reaction 
is defined as the amount of deaminated product produced by a given amount of AID 
enzyme in a unit of time and plotted against substrate concentration. At 32°C Hs-AID 
reached its maximum enzymatic potential (the greatest reaction velocities at 32°C, 37°C, 
and 41°C were 0.195, 0.099, and 0.024 fmol product/ugAID/min, respectively, at the 
point of maximal difference). 
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Figure 20: Comparison of deamination kinetics of Dr-AID under different 
temperature conditions. 
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Figure 20: Comparison of deamination kinetics of Dr-AID under different 
temperature conditions. 
The deamination kinetics of Dr-AID on TGCbub7 substrate was tested and compared at 
16°C, 27°C, and 33°C. The velocity of the reactions was measured as a function of 
substrate concentration over a 120 fold dilution range (0.25-30 nM). In vitro, Dr-AID 
showed the greatest velocity of product formation at 27°C (the greatest reaction velocities 
at 16°C, 27°C, and 31°C were 0.60, 1.30, and 0.66 fmol product/ugAID/min, 
respectively, at the point of maximal difference). The velocity of AID reaction is defined 
as the amount of deaminated product produced by a given amount of AID enzyme in a 
unit of time and plotted against substrate concentration. 
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4. Discussion 
4.1 Overall rationale and significant findings 
The discovery of AID and its recognition as the master switch that initiates all 
secondary diversification of antibodies has paved the way for a much deeper 
understanding of the molecular processes of somatic hypermutation (SHM) and class 
switch recombination (CSR). AID is expressed in activated mature B lymphocytes and 
performs its biological function by deaminating cytidines to uridines, thus introducing 
mutations and/or double-strand breaks throughout the immunoglobulin (Ig) locus. 
Although that AID activity is mostly directed to the Ig locus, it targets other genes at 
lower rates and this activity induces genomic lesions leading to transformation of B cells.  
Despite the fact that numerous studies have been conducted to comprehend the 
biochemical functions of AID, its structure has not been determined, leaving many 
questions unanswered about the enzymatic mechanism. Our lab has recently shown that 
AID from different species have varied deamination activity levels, and that the 
deamination efficiency of AID from each species is temperature dependent 
(thermosensitive), such that human AID is more catalytically active at the human body 
temperature, and less so at lower temperatures (e.g. 25°C & 18°C) (Dancyger et al., 
2012). The opposite is true for bony fish AID. 
 Our goal here was to begin to understand the nature of AID's thermosensitivity by 
defining the important structures or regions of AID that are responsible for 
thermosensitivity and by quantitating the degree of differences in activity across 
temperatures. In particular, we conducted a comparative study to elucidate this property 
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of human AID versus the most divergent bony fish AIDs. Our aim was to identify 
region(s) and/or residue(s) within the enzyme which are important for this biochemical 
characteristic. In doing so, we hoped to elucidate the fundamental relationship between 
the thermosensitivity of AID and its primary structure, and provide the foundation for 
doing so with the tertiary structure in the future. Here, we purified human, zebrafish, 
pufferfish, and, channel catfish AIDs. Hybrid AID enzymes, containing various portions 
of the aforementioned, were constructed, purified, and tested to narrow down the 
region(s) that regulate AID thermosensitivity. These hybrid AIDs were tested along with 
the wild type AID enzymes over a wide range and fine increments of temperatures to 
precisely determine the optimal temperatures and thermosensitivity patterns of each 
purified AID enzyme. We hypothesized that the thermosensitivity of AID is a 
characteristic that is based in one region and can be transferred from one species to 
another by swapping said region. Otherwise, this property might be attributed to the 
overall conformational structures of AID in a way that requires residues located 
throughout the enzyme, to function in combination, rather than a specific region. There 
are two main findings in this thesis. The first is that the thermosensitivity of AID is 
mainly a C-terminal based feature. Secondly, we found that human AID reached its 
maximum enzymatic potential and greatest velocity of product formation at 32°C instead 
of the previously assumed 37°C.  
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4.2 The optimal temperature for human AID 
Initially, most of our experiments to test human and bony fish AIDs were carried 
out at three different temperatures 37°C, 25°C, and 18°C. As already rationalized, 37°C 
was suggested as the optimal temperature for human AID to deaminate its target 
substrate, based on the facts that the optimum temperature for most human enzymes lies 
between 35°C and 40°C, and that the body temperature is 37°C. On the other hand, 18°C 
and 25°C were chosen to represent two distant water temperatures in which bony fish 
involved in this study naturally live. It is important to note that many fish live in 
temperature well below this range (e.g. arctic cod), and characterizing their 
thermosensitivity is a future research direction in our lab. Admittedly, human AID in 
vitro was always more catalytically active at 37°C in comparison to 25°C and 18°C, and 
its enzymatic activity was diminished as temperature was decreased to such low 
temperatures (figure 10). One possible explanation for the reduced activity of human AID 
at 25°C and 18°C could be that human AID at these low temperatures underwent some 
conformational changes, possibly within the DNA binding groove which would result in 
reducing the substrate affinity as well as diminishing the catalytic efficiency of the 
enzyme. In support of this possibility, previous work in our lab showed that fish AID 
bound DNA with higher affinity at colder temperatures (Dancyger et al., 2012). However, 
this does not rule out the possibility that a broader conformational change in the enzyme 
beyond the binding groove is responsible for the diminished activity of human AID. In 
line with this possibility, another reason for the reduced activity of human AID can be 
ascribed to low molecular flexibility at colder temperatures. A previous study has 
revealed that the warm-adapted enzymes in general are structurally rigid and have 
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reduced catalytic efficiencies at low temperatures (Eijsink, et al., 2004). However, when 
human AID was tested in vitro over wider range and fine increments of temperatures to 
accurately determine the optimal temperature for human AID, we noticed that human 
AID is actually optimal at 32°C than at 37°C (figure 12). We confirmed that this optimal 
activity at 32°C rather than at 37°C, was a true and significant enzymatic property by 
showing that Hs-AID exhibited greater catalytic velocity at 32°C than at 37°C (figure 19). 
  This is the first study to show that human AID is optimally active at 32°C.  
However, if the ideal temperature for human AID in vivo is indeed not 37°C, then this 
might be a unique (or uncommon) regulatory feature associated with the biochemical 
characteristics of this enzyme. In other words, the notion that our body temperature is a 
slightly sub-optimal temperature for Human AID activity may represent an inherently 
"built-in" mechanism (an evolutionary mechanism) of limiting AID activity, in particular 
its off-target “deleterious” genome-damaging activities (that cause genomic lesions and 
lead to transformation of B cells) of Hs-AID in our bodies. In this context, it is interesting 
to mention that previous work by our group has demonstrated that human AID has a 
number of unique characteristics such as a very slow rate of deamination activity and 
unusual high affinity binding to ssDNA (Larijani, et al., 2007) that have also been 
suggested to restrict its off-target mutagenic activity in vivo (Pham et al., 2007; Coker & 
Petersen-Mahrt, 2007; Larijani & Martin, 2012; Dancyger et al., 2012). Alternatively, this 
evolutionary feature may not serve an important biological function, but may simply be a 
by-product of the evolution of AID to become more warm-adapted than fish AID, but to a 
level that has not yet reached 37°C.   
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4.3 Thermosensitivity mechanisms of human and bony fish AIDs  
Earlier studies have shown that various species have evolved in dissimilar 
conditions, causing them to adapt to different thermal environments (Feller & Gerday, 
2003; Smalas, 2000; D’Amico et al., 2002; Somero, 2004; Siddiqui & Cavicchioli, 2006). 
Also, previous work in our lab has shown that human and bony fish AIDs have disparate 
enzymatic activities when they are subjected to different thermal conditions (Dancyger et 
al., 2012). Here we showed that human AID in vitro has unexpectedly obtained its 
maximum deamination activity at 32°C (figure 12), but it was catalytically sensitive to 
temperatures lower than 32°C. In addition, some recent lines of evidence indicate that 
warm-adapted enzymes (e.g. human enzymes) are generally characterized by being 
structurally rigid at low temperatures (Eijsink, et al., 2004). This may be the reason for 
the reduced deamination activity of human AID observed at temperatures lower (or even 
higher) than 32°C. In contrast, we noticed that bony fish AIDs involved in our study are 
adapted to temperatures around 25°C, but their catalytic rates decreased as temperature 
was increased (figure 12). This was not surprising, since these are natural water 
temperatures where some bony fish (e.g., zebrafish and channel catfish) normally live 
(Shrable et al., 1969; Chen 1976; Spence et al., 2006). These findings brought forth the 
question of what kind of adjustments have resulted in the adaptation of human and bony 
fish AIDs to disparate temperatures. One possible explanation for the cold adaptation of 
bony fish AIDs could be that these enzymes may have developed some structural features 
(e.g. divergent amino acid residue(s) or different loop structure(s) at the primary 
structural level or at the three dimensional level, respectively, that somehow provided 
these enzymes with a higher molecular flexibility, particularly around the catalytic site, 
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and high specific deamination activity at low temperatures compared to the warm-adapted 
enzymes. In this context, it is noteworthy to mention that some studies showed that the 
non-catalytic regions (N-terminal and C-terminal regions) of the cold-adapted enzymes 
have preserved relative stability, while the catalytic regions have evolved certain 
plasticity to  bind the substrate at low temperatures (D’Amico S, et al., 2002). An 
interesting finding in our study was that human AIDs whose N-terminal or catalytic 
regions were interchanged with the equivalent regions of bony fish AIDs (e.g. HDH, 
HIH, DHH, THH, DDH) did not alter their thermosensitivity patterns and their optimal 
temperatures remained very close to that of human AID (figure 11-A, 14, 16, and 18). 
This suggests that swapping these regions (N-terminal or catalytic regions) between 
human and bony fish AIDs does not transfer the optimal temperatures or the 
thermosensitivity from one species to another. In good agreement with our findings, a 
previous study on a hybrid human AID (composed of human AID with a catalytic region 
of takifugu AID), using both a bacterial rifampicin-rescue assay and a GFP-stop-codon-
reversion assay done in HEK293 cells, revealed that the thermosensitivity of this hybrid 
human AID was not affected and still has strong enzymatic activity at 37°C (Ichikawa et 
al., 2006; Barreto & Magor, 2011). These results further confirmed that this biochemical 
property of AID lies outside the catalytic (Zn coordinating) region, and it also provided 
additional in vivo relevance to our observations, by showing that the same trends we are 
measuring in our in vitro assays on purified GST-AID have been observed when studying 
AID activity inside cells.  
A previous study on the three dimensional structures of cold-adapted enzymes 
revealed that the amino acid residues located in the active site of these enzymes are 
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generally highly conserved with their warm-adapted equivalents, and only few 
conformational adjustments/modifications are required for the warm-adapted enzymes to 
adapt to low temperatures, and that these minor  modifications responsible for the 
adaptive changes have to be located outside the active site (Field & Somero, 1998; 
D’Amico et al., 2002). All our findings thus far support the notion that the 
thermosensitivity of AID is mostly a C-terminal region-based characteristic and swapping 
this region can transfer this feature from one species to another (figure 18). However, it 
remains to be determined whether this may be a single amino acid residue that harbors 
this biochemical property or a combination of amino acids or small segments that might 
be continuously or dis-continuously located in the C-terminal region of AID.  
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4.4 Conclusion and future directions 
In this study, we endeavoured to shed light on the temperature-adaptive variation 
between human and bony fish AIDs. For that reason, AID of human, zebrafish, catfish 
and pufferfish were purified and examined over a wide range of temperatures. 
Intriguingly, human AID was optimally active at 32°C and not at 37°C as we initially 
expected, whereas the average ideal temperatures for bony fish AIDs examined in this 
study were 22°C for catfish AID and 27°C for zebrafish AID. Also, we compared the 
deamination kinetics of human AID at 37°C versus 32°C; this further confirmed that 
human AID is more catalytically robust at 32°C. We also sought to determine the portions 
of AID's primary structure that led to these adaptive differences in the thermosensitivity 
of AID among species. Hybrid AID enzymes composed of various segments of human 
and bony fish AIDs were constructed, purified, and tested along with the wild type AIDs 
under the same substrate and temperature conditions. We found that the thermosensitivity 
of AID is mediated by the C-terminal region. However, since our hybrid AIDs were 
constructed based on dividing the primary structure of AID into three linear regions, and 
not based on structure modeling, more ongoing and future work is required to design new 
hybrids by swapping regions that encode putative three-dimensional structural features. 
Extensive modeling will be used to identify divergent structural loops in the C-terminal 
region of human and bony fish AIDs. The loops that have divergent conformational 
structures will be swapped between species with the premise that this may influence the 
thermosensitivity and reveal "structural features" rather than primary sequences (as was 
done here) that regulate this enzymatic feature of AID. Also, more species (e.g. various 
cold and warm adapted organisms) will be included in future studies on this biochemical 
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property of AID. It will be of particular interest to test the thermosensitivity of AID from 
bony fish that inhabit extremely cold temperatures such as the North Atlantic and Arctic. 
In addition, specific mutants of AID, focusing on the C terminus region, will be generated 
harboring multiple mutations that have altered their thermosensitivity; in order to more 
precisely map the origin and mechanism of this enzymatic characteristic. Furthermore, 
circular dichroism (CD) can be utilized to study and compare the folding mechanism and 
stability of the cold- vs. warm-adapted AIDs at different temperatures, which will test the 
"unfolding" hypothesis presented in this thesis. In the long-term, it will also be of interest 
to determine the mutagenic activity of human AID at different temperatures (e.g. at 32°C 
vs. 37°C) by measuring double stranded breaks mediated by this enzyme inside cells, to 
further confirm the notion that 37°C is a slightly sub-optimal temperature for Hs-AID 
activity and that this may represent an inherently built in restriction to AID's off-target 
activities. 
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